Skip to main content

Establishment profile

ASPIRE PHARMACEUTICALS

41 VERONICA AVE, SOMERSET, NJ, 08873
325411Medicinal and Botanical Manufacturing

Download as PDF →

OSHA inspections
2
over 1 year
Violations
4
$44,685 in penalties
Penalties
$44,685
$11,171 avg
Violations across 2 federal agencies
Enforcement actions from multiple agencies may indicate systemic compliance issues across functions.
Accident investigations on record
1 National Emphasis Program inspections

Summary

ASPIRE PHARMACEUTICALS has accumulated 4 OSHA violations across 2 inspections over 1 year of recorded history, with $44,685 in total assessed penalties.

The establishment sits in the 64th percentile for violations within its industry-state peer group of 180 employers. Inspection frequency runs at the 60th percentile. The most recent enforcement activity was recorded 6 months ago.

Federal records were found in 2 of 15 sources. Sources without matching records returned empty for this establishment.

Agency coverage

ASPIRE PHARMACEUTICALS appears in OSHA workplace safety, EPA environmental compliance, OFLC visa and labor certification (historical), and FMCSA motor carrier registration records only. No matching records were found in WHD wage enforcement, MSHA mine safety, NLRB labor relations, SAM.gov federal debarment, CMS nursing home enforcement, CPSC product recalls, or NHTSA vehicle recalls.

OSHA workplace safety

Inspections
2
2.0 / yr · last 1 yrs
Violations
4
4.0 / yr
Penalties
$44,685
$11,171 avg / violation
Inspection trigger · referral
2 of 2

100% of inspections at this establishment produced violations,

Most-cited OSHA standards

Top OSHA standards cited at this employer, ranked by citation count. Standards (CFR sections) cluster citations into safety themes -- machine guarding, lockout-tagout, hazard communication, fall protection, process safety, etc. A concentration on one or two sections reveals a pattern that individual citations don’t. 4 distinct standards shown · 4 citations in this view · $44,685 in penalties.

CFR sectionCitationsInspectionsTotal penaltyFirst citedLast cited
29 CFR 1910.0147 C06 I11$11,916Oct 2025Oct 2025
29 CFR 1910.0147 D0211$11,916Oct 2025Oct 2025
29 CFR 1910.0147 C04 I11$10,427Jul 2026Jul 2026
29 CFR 1910.0212 A03 II11$10,427Jul 2026Jul 2026

Source: OSHA inspection citations (violation_detail). CFR section codes can be looked up at osha.gov/laws-regs for the formal standard text. Per-inspection detail and the specific violation descriptions are available by expanding individual inspections below.

Peer comparison

64th

Above average violations in NAICS 3254 within NJ. Peer group: 180 employers. This establishment has 4 OSHA violations; peer median is 2.

Fewer violationsMore violations
Penalty percentile
97th
peer median: $1,901
Inspection frequency
60th
peer median: 1

Safety self-report (OSHA 300A)

No self-reported injury rates filed with OSHA's Injury Tracking Application for ASPIRE PHARMACEUTICALS. Verify directly with OSHA Injury Tracking Application

Industry benchmark

Industry avg TRIR
1.4
BLS SOII 2024
Industry avg DART
1.0
BLS SOII 2024
Self-reported TRIR
Not in OSHA ITA

BLS rates reflect industry-wide averages. Self-reported figures come from OSHA’s Injury Tracking Application; absence of self-reported data does not necessarily indicate non-compliance — many establishments fall below the ITA reporting threshold.

Inspection breakdown

Referral
2

Complaint- and accident-triggered inspections are stronger risk signals than routine planned inspections.

OSHA severe injury reports

Self-reported events under 29 CFR 1904.39 (24-hour notification of hospitalization, amputation, or loss of an eye) · Apr 2025

Reports
1
Hospitalizations
1
Amputations
1
Eye losses
0

Most frequent event: Struck by running powered equipment during maintenance, cleaning, testing

Source: OSHA Severe Injury Reports (federal OSHA only; state-plan states like California, Oregon, and Washington maintain their own programs and do not consistently report into this feed).

Severe injury reports — events

Each row is a hospitalization, amputation, or eye-loss event the employer self-reported to OSHA under 29 CFR 1904.39. Narratives are written by the reporting employer.

DateEventBody partOutcome
Apr 24, 2025Struck by running powered equipment during maintenance, cleaning, testingFinger or thumb tip(s), nail(s)Amputation

Source: OSHA Severe Injury Reports. Federal-OSHA jurisdiction only by default; some state-plan programs report voluntarily.

Activity timeline

Data refreshed
Weekly
First OSHA inspection
Most recent activity
6 months ago

Most recent federal enforcement activity recorded 6 months ago. Data on this page is refreshed weekly.

Wage & Hour Division (WHD)

No WHD wage, overtime, or child-labor enforcement cases on file for ASPIRE PHARMACEUTICALS. Verify directly with Wage and Hour Division

Mine safety (MSHA)

No MSHA mine safety violations on file for ASPIRE PHARMACEUTICALS. Verify directly with Mine Safety and Health Administration

Labor relations (NLRB)

No NLRB unfair labor practice charges or union representation cases on file for ASPIRE PHARMACEUTICALS. Verify directly with National Labor Relations Board

Visa & labor certification (OFLC) — historical

Total applications
5
Certified
5
Avg wage ratio
1.13x
H-1B

Office of Foreign Labor Certification — labor condition applications for H-1B, H-2A, H-2B visa programs. Wage ratio = offered / prevailing wage. Historical data only: DOL ended OFLC Performance Data Disclosure publication in 2026, so the figures above reflect filings through the last ingested cycle and are not being refreshed. Treat as a historical snapshot, not a current signal.

Environmental compliance (EPA)

EPA inspections
1
Quarters non-compliant
2

EPA Enforcement and Compliance History — Clean Air Act, Clean Water Act, RCRA, Safe Drinking Water Act. Status: No Violation Identified.

EPA-registered facilities

Every EPA ECHO facility associated with this employer, sorted most-significant first. Each row links to EPA’s Detailed Facility Report for the source-of-truth record. Permits column lists active programs (Air = Clean Air Act, Water = Clean Water Act, RCRA = hazardous waste, TRI = Toxics Release Inventory reporting). 1 facility.

FacilityPermitsStatusInspectionsFormal actionsPenaltiesLast inspectedECHO
ASPIRE PHARMACEUTICALS INC
37 VERONICA AVENUE · SOMERSET, NJ, 08873
RCRANo Violation Identified
QNCR 2
10Feb 2024View →

Source: EPA ECHO (Enforcement and Compliance History Online). Compliance status follows EPA’s own labels (“Sig Violation” = significant noncompliance; QNCR = quarters of noncompliance over the recent reporting window). Inactive facilities (struck through) retain historical enforcement records even after operations ceased.

Motor carrier safety (FMCSA)

DOT number
3043275
Operation
C

Federal Motor Carrier Safety Administration — DOT-regulated carrier registration and fleet data.

Inspection history

DateTriggerViolationsSeriousPenalty
2026-03-06Referral2$20,853
2025-04-29Referral2$23,832

Source: OSHA IMIS. Citation amounts reflect initially assessed penalties; final amounts after appeal may differ.

In the news

Other employers in this industry and state

Other employers in medicinal and botanical manufacturing within NJ, ordered by federal enforcement volume:

Related searches

About this data

This profile aggregates federal enforcement records on ASPIRE PHARMACEUTICALS from every major federal compliance and enforcement source. OSHA workplace safety inspections, WHD wage cases, MSHA mine safety, EPA environmental enforcement, NLRB labor relations, OFLC visa/labor certification, FMCSA motor carrier registration, SAM.gov debarments, CMS nursing-home records, BLS industry safety benchmarks, OSHA ITA self-reported injury rates, SEC enforcement and financial disclosures, CPSC and NHTSA recalls.

Establishments are matched across agencies using normalized employer name, state, and ZIP code.

OSHA citations typically appear 3–8 months after the inspection, so very recent enforcement actions may not yet be reflected. Profiles may be incomplete if the establishment operates under multiple legal names or files under variations our entity-matching rules don’t yet cover. To report a missing record or correction, email corrections@fastdol.com.

Need API access, bulk download, or licensed redistribution? The website is free. Programmatic and licensed access is handled separately.

Contact sales →

Frequently asked

What is ASPIRE PHARMACEUTICALS's OSHA violation history?
ASPIRE PHARMACEUTICALS has 2 OSHA inspections on record with 4 violations and $44,685 in total penalties.
How does ASPIRE PHARMACEUTICALS's safety record compare to its industry?
ASPIRE PHARMACEUTICALS operates in the medicinal and botanical manufacturing industry. The industry average Total Recordable Incident Rate (TRIR) is 1.4.